Vital Therapies
Why Robinhood?
You can watch VTL and buy or sell other stocks, ETFs, and their options commission-free!About VTL
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
VTL Key Statistics
Stock Snapshot
The current Vital Therapies(VTL) stock price is $7.76, with a market capitalization of 102.61M. The stock trades at a price-to-earnings (P/E) ratio of -1.68.
On 2026-11-15, Vital Therapies(VTL) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Vital Therapies(VTL) stock has reached 0, versus its average volume of 200.29K.
The stock's 52-week range extends from a low of $5.06 to a high of $17.43.
The stock's 52-week range extends from a low of $5.06 to a high of $17.43.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.